ZINZINO AB (PUBL): PRELIMINARY SALES REPORT APRIL 2023
Zinzino group revenue increased with a total of 20%, compared with the previous year.
The revenue in April for Zinzino's sales markets increased by 22% and amounted to SEK 115.9 (95.0) million. Faun Pharma's external sales decreased by 9% and amounted to SEK 5.3 (5.8) million. Overall, the Group increased revenues by 20% to SEK 121.2 (100.8) million compared with the previous year.
Accumulated revenue for January – April 2023 increased by 18% to SEK 514.9 (435.2) million.
Revenues were distributed as follows:
| Regions,MSEK | 23-Apr | 22-Apr | Change | YTD 2023 | YTD 2022 | Change |
| The Nordics | 21.5 | 24.5 | -12% | 95.0 | 104.7 | -9% |
| Central Europe | 29.1 | 19.8 | 47% | 120.0 | 78.9 | 52% |
| East Europe | 30.5 | 23.8 | 28% | 123.1 | 107.2 | 15% |
| South & West Europe | 15.6 | 11.0 | 42% | 64.6 | 49.2 | 31% |
| The Baltics | 7.0 | 5.1 | 37% | 28.1 | 23.4 | 20% |
| North America | 5.9 | 4.4 | 34% | 25.5 | 18.5 | 38% |
| Asia-Pacific | 5.3 | 5.9 | -10% | 20.9 | 22.3 | -6% |
| Africa | 1.0 | 0.5 | 100% | 4.8 | 1.9 | 153% |
| Zinzino | 115.9 | 95.0 | 22% | 482.0 | 406.1 | 19% |
| Faun Pharma | 5.3 | 5.8 | -9% | 32.9 | 29.1 | 13% |
| Zinzino Group | 121.2 | 100.8 | 20% | 514.9 | 435.2 | 18% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
marketing@zinizno.com
Certified Adviser:
Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino owns the Swiss, biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, the US and Australia.